Showing results (121-130 of 203) with videos related to

Sort By:
Pageof 21
Arthritis & Rheumatology (Hoboken, N.J.)|April 21, 2017
Twenty-Year Outcome and Association Between Early Treatment and Mortality and Disability in an Inception Cohort of Patients With Rheumatoid Arthritis: Results From the Norfolk Arthritis RegisterJames M Gwinnutt, Deborah P M Symmons, Alexander J MacGregor, et al.
Rheumatology (Oxford, England)|March 23, 2018
Long-term persistence with rituximab in patients with rheumatoid arthritisAlexander G S Oldroyd, Deborah P M Symmons, Jamie C Sergeant, et al.
Rheumatology (Oxford, England)|May 26, 2016
Predictors and outcomes of sustained, intermittent or never achieving remission in patients with recent onset inflammatory polyarthritis: results from the Norfolk Arthritis RegisterMichael J Cook, Janet Diffin, Carlo A Scirè, et al.
American Journal of Epidemiology|February 22, 2021
Propensity Score Weighting and Trimming Strategies for Reducing Variance and Bias of Treatment Effect Estimates: A Simulation StudyTil Stürmer, Michael Webster-Clark, Jennifer L Lund, et al.
Annals of the Rheumatic Diseases|February 25, 2018
Have the 10-year outcomes of patients with early inflammatory arthritis improved in the new millennium compared with the decade before? Results from the Norfolk Arthritis RegisterJames M Gwinnutt, Deborah P M Symmons, Alexander J MacGregor, et al.
The Journal of Investigative Dermatology|March 6, 2015
Psoriasis and the Risk of Major Cardiovascular Events: Cohort Study Using the Clinical Practice Research DatalinkRosa Parisi, Martin K Rutter, Mark Lunt, et al.
Rheumatology (Oxford, England)|March 12, 2010
The role of rheumatoid arthritis genetic susceptibility markers in the prediction of erosive disease in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis RegisterDarren Plant, Wendy Thomson, Mark Lunt, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 11, 2016
Association Between Ischemic Stroke and Tumor Necrosis Factor Inhibitor Therapy in Patients With Rheumatoid ArthritisAudrey S L Low, Mark Lunt, Louise K Mercer, et al.
The British Journal of Dermatology|May 25, 2023
Effectiveness and survival of methotrexate versus adalimumab in patients with moderate-to-severe psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)Oras A Alabas, Kayleigh J Mason, Zenas Z N Yiu, et al.
Annals of the Rheumatic Diseases|April 2, 2014
Risk of solid cancer in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid ArthritisLouise K Mercer, Mark Lunt, Audrey L S Low, et al.
Pageof 21